A Structural Transformation in the Primary CRO Business Model to a More Strategic Approach Has Revolutionized R&D Outsourcing - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/lglq28/specialty_cros) has announced the addition of the "Specialty CROs Market, 2016 - 2025" report to their offering.

The Specialty CROs Market, 2016-2025 report delivers a comprehensive study on Contract Research Organizations (CROs) that provide a specialized set of research capabilities centred on a particular stage of clinical development or a range of services in a focused therapeutic area. The outsourcing model has proven to be extremely beneficial to drug developers catering to the unmet research, clinical development and even regulatory needs of both established players and start-ups in the market.

The report assesses key drivers that have governed the evolution of specialty CROs over the past several years, along with an elaborate discussion on the upcoming trends that will likely shape the market in the coming years. In fact, one of the primary objectives of this study is to develop an understanding of the likely future evolution of the market for specialty CROs over the short-term and long-term.

The future evolution of this market will be primarily driven by the relatively fast paced growth of the overall pharma industry and the innovations / developments taking place in R&D. The report provides short-midterm and long-term market forecasts for the period 2016-2020 and 2020-2025, respectively. To add robustness to our forecast model, we have provided three market scenarios. The conservative, base and optimistic scenarios represent three different tracks of market evolution.

The research, analysis and insights presented in this report are backed by a comprehensive survey on capabilities of several specialty CROs. For the purpose of our analysis, we also interviewed important stakeholders in this market to solicit their opinions around the future opportunities and challenges that must be considered for a more inclusive growth.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Specialty CROs: An Introduction

5. Market Overview

6. Specialty CROs: Focused On Services

7. Specialty CROs: Focused On Therapeutic Areas

8. Case Study I: Virtual CROs

9. Case Study Ii: Full Service CROs

10. Market Forecast

11. Future Opportunities

12. Conclusion

Companies Mentioned:

  • Abiogenesis Clinpharm
  • Accell Clinical Research
  • Accelovance
  • Aclires
  • Acquipharma
  • Afraxis
  • Agence Africaine de Recherche en Santé Humaine
  • Agility Clinical
  • Agilux Laboratories
  • AHRM
  • AIT Bioscience
  • Aklima Clinical Research
  • Alera Labs
  • Alimentix
  • Alliance Pharma
  • Allied Clinical Management
  • Allostem Therapeutics
  • Almedis
  • Alpha CRO
  • Alpha Stats
  • (300+ More)

For more information visit http://www.researchandmarkets.com/research/lglq28/specialty_cros

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals